glutathione acetyl-glutathione fluoroquinolone Antioxidants as adjuvant therapy in
Description
Yusuke Mori (Yamashita Thyroid Hospital)
doi: 10.1002/jat.3303 73 PizzinoG.IrreraN.CucinottaM.PallioG.ManninoF.ArcoraciV.et al
doi: 10.1021/acs.nanolett.1c03004
Giorgio I
The key is coordinating the IPR timeline with the ANDA prosecution to ensure that a favorable PTAB decision can be translated into earlier approval and launch, rather than simply establishing invalidity after the commercial window has closed
